Premium
Differential Regulation of MHC Class‐I‐Restricted and Unrestricted Cytotoxicity by the Us3 Protein Kinase of Herpes Simplex Virus‐1
Author(s) -
Cartier A.,
Masucci M. G.
Publication year - 2004
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.0300-9475.2004.01523.x
Subject(s) - lymphokine activated killer cell , mhc class i , cytotoxic t cell , biology , herpes simplex virus , natural killer cell , virology , major histocompatibility complex , granzyme b , cytotoxicity , cytolysis , effector , cd8 , immunology , virus , interleukin 21 , immune system , biochemistry , in vitro
Modulation of cytotoxic responses by viral immunoevasins plays an important role in the establishment of latent and persistent viral infections. Together with MHC class‐I‐restricted CD8T‐lymphocytes, non‐MHC‐restricted natural killer (NK) and lymphokine‐activated killer (LAK) cells participate in this anti‐viral control. The Us3 protein kinase of herpes simplex virus‐1 (HSV‐1) inhibits CD8T‐cell cytotoxicity, which correlates with the inhibition of granzyme‐B (GrB)‐induced activation of pro‐apoptotic Bid. We have investigated the effect of Us3 on NK and LAK cytotoxicity, because these effectors are believed to share common mechanisms for inducing cell death. We show that, in contrast to their lower sensitivity to CD8T‐cell lysis, HSV‐1‐infected cells are lysed by NK cells or LAK cells as efficiently as the uninfected controls. Both CD8T and NK/LAK effectors were dependent on the activity of GrB and were efficiently blocked by means of treatment with a GrB inhibitor. However, unlike CD8T cells, LAK cells and NK cells failed to induce Bid cleavage, suggesting that various GrB downstream targets be involved in the induction of cell lysis. This finding explains their various sensitivities to viral modulation, which is likely to be important for the respective role of MHC‐restricted and non‐restricted effectors in the control of HSV‐1 infection.